RS
IGMS

R Squared’s IGM Biosciences IGMS Stock Holding History

R Squared’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-370
Closed -$2.26K – 853
2024
Q4 		$2.26K Buy
+370
New +$4.4K ﹤0.01% 1448

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

R Squared's IGMS Position: Q1 2025 in Review

R Squared sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 370 shares — an estimated $2.26K sold.

R Squared first reported a position in IGMS in Q4 2024 and held it in 1 quarter. The position peaked at $2.26K in Q4 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • R Squared reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 370 IGM Biosciences shares in Q1 2025, an estimated $2.26K.
  • R Squared first reported a position in IGM Biosciences in Q4 2024 and held it in 1 quarter.
  • R Squared's IGM Biosciences position peaked at $2.26K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.